X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
4.040
+0.010 (0.25%)
At close: Aug 21, 2026, 4:00 PM EDT
4.127
+0.087 (2.15%)
After-hours: Aug 21, 2026, 7:30 PM EDT
X4 Pharmaceuticals Employees
X4 Pharmaceuticals had 45 employees as of December 31, 2025. The number of employees decreased by 98 or -68.53% compared to the previous year.
Employees
45
Change (1Y)
-98
Growth (1Y)
-68.53%
Revenue / Employee
$352,156
Profits / Employee
-$2,003,067
Market Cap
400.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -98 | -68.53% |
| Dec 31, 2024 | 143 | 50 | 53.76% |
| Dec 31, 2023 | 93 | 23 | 32.86% |
| Dec 31, 2022 | 70 | -13 | -15.66% |
| Dec 31, 2021 | 83 | 11 | 15.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Lyell Immunopharma | 161 |
| Enanta Pharmaceuticals | 120 |
| Arcturus Therapeutics Holdings | 111 |
| Foghorn Therapeutics | 106 |
| Upstream Bio | 75 |
| Lexeo Therapeutics | 63 |
| Fennec Pharmaceuticals | 35 |
XFOR News
- 15 days ago - X4 Pharmaceuticals reports Q2 EPS (13c), consensus (18c) - TheFly
- 15 days ago - X4 Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 16 days ago - X4 Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 16 days ago - X4 Pharmaceuticals Earnings release: Q2 2026 - Filings
- 18 days ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - X4 Pharmaceuticals initiated with an Overweight at Wells Fargo - TheFly
- 6 weeks ago - X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - X4 Pharmaceuticals appoints CAMP4 Therapeutics CFO Kelly Gold to board - TheFly